ADEL MAHMOUD (Chair), President, Merck Vaccines, Whitehouse Station, New Jersey

STANLEY LEMON (Vice-Chair), Dean, School of Medicine, The University of Texas Medical Branch, Galveston, Texas

DAVID ACHESON, Chief Medical Officer, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Rockville, Maryland

STEVEN BRICKNER, Research Advisor, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut

GAIL CASSELL, Vice President, Scientific Affairs, Eli Lilly & Company, Indianapolis, Indiana

GORDON DEFRIESE, Professor of Social Medicine, University of North Carolina, Chapel Hill, North Carolina

CEDRIC DUMONT, Medical Director, Department of State and the Foreign Service, Washington, DC

JESSE GOODMAN, Deputy Director, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland

EDUARDO GOTUZZO, Director, Instituto de Medicina Tropical, “Alexander von Humbolt” Universidad Peruana Cayetano Herdia, Lima, Peru

RENU GUPTA, Vice President and Head, U.S. Clinical Research and Development, and Head, Global Cardiovascular, Metabolic, Endocrine, and G.I. Disorders, Novartis Corporation, East Hanover, New Jersey

MARGARET HAMBURG, Vice President for Biological Programs, Nuclear Threat Initiative, Washington, DC

CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

DAVID HEYMANN, Executive Director, Communicable Diseases, World Health Organization, Geneva, Switzerland

JAMES HUGHES, Assistant Surgeon General and Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

SAMUEL KATZ, Wilburt C. Davison Professor and Chairman Emeritus, Duke University Medical Center, Durham, North Carolina

PATRICK KELLEY, Colonel, Director, Department of Defense Global Emerging Infections System, Walter Reed Army Institute of Research, Silver Spring, Maryland

MARCELLE LAYTON, Assistant Commissioner, Bureau of Communicable Diseases, New York City Department of Health, New York, New York

JOSHUA LEDERBERG, Raymond and Beverly Sackler Foundation Scholar, The Rockefeller University, New York, New York

CARLOS LOPEZ, Research Fellow, Research Acquisitions, Eli Lilly Research Laboratories, Indianapolis, Indiana

LYNN MARKS, Global Head of Infectious Diseases, GlaxoSmithKline, Collegeville, Pennsylvania

STEPHEN MORSE, Director, Center for Public Health Preparedness, Columbia University, New York, New York

MICHAEL OSTERHOLM, Director, Center for Infectious Disease Research and Policy, and Professor, School of Public Health, University of Minnesota, Minneapolis, Minnesota

GARY ROSELLE, Program Director for Infectious Diseases, VA Central Office, Veterans Health Administration, Department of Veterans Affairs, Washington, DC

DAVID SHLAES, Executive Vice President for Research and Development, Idenix, Cambridge, Massachusetts

JANET SHOEMAKER, Director, Office of Public Affairs, American Society for Microbiology, Washington, DC

P. FREDRICK SPARLING, J. Herbert Bate Professor Emeritus of Medicine, Microbiology, and Immunology, University of North Carolina, Chapel Hill, North Carolina

MICHAEL ZEILINGER, Infectious Disease Team Leader, Office of Health and Nutrition, U.S. Agency for International Development, Washington, DC

ENRIQUETA BOND, President, Burroughs Wellcome Fund, Research Triangle Park, North Carolina

NANCY CARTER-FOSTER, Director, Program for Emerging Infections and HIV/AIDS, U.S. Department of State, Washington, DC

EDWARD McSWEEGAN, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

STEPHEN OSTROFF, Associate Director for Epidemiologic Science, National Center for Infectious Diseases. Centers for Disease Control and Prevention, Atlanta, Georgia

DEAN T. JAMISON (Chair), Senior Fellow, Fogarty International Center, National Institutes of Health

YVES BERGEVIN, Chief, Health Section, UNICEF

PATRICIA DANZON, Professor, Health Care Systems Department, University of Pennsylvania

RICHARD FEACHEM, Interim Secretariat, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva

NOREEN GOLDMAN, Professor, Office of Population Research, Princeton University, Princeton, New Jersey

MARGARET HAMBURG, Vice President for Biological Programs, Nuclear Threat Initiative, Washington, DC

GERALD KEUSCH, Director, Fogarty International Center, National Institutes of Health

ARTHUR KLEINMAN, Maude and Lillian Presley Professor of Medical Anthropology/ Professor of Psychiatry and Social Medicine, Harvard Medical School

ADEL MAHMOUD, President, Merck Vaccines

JOHN WYN OWEN, Secretary, Nuffield Trust, London

ALLAN ROSENFIELD, Dean, Mailman School of Public Health, Columbia University

SUSAN SCRIMSHAW, Dean, School of Public Health, University of Illinois at Chicago

JUDITH BALE, Director, Board on Global Health (retired December 2002)

STACEY L. KNOBLER, Director, Forum on Emerging Infections

MARK S. SMOLINSKI, Senior Program Officer

PATRICIA CUFF, Research Associate

MARJAN NAJAFI, Research Associate

KATHERINE OBERHOLTZER, Project Assistant

JASON PELLMAR, Project Assistant

The Infectious Etiology of Chronic Diseases

in press

The Impact of Globalization on Infectious Disease Emergence and Control

in press

The Resistance Phenomenon in Microbes and Infectious Disease Vectors

Implications for Human Health and Strategies for Containmemt

2003

The Emergence of Zoonotic Diseases

Understanding the Impact on Animal and Human Health

2002

Considerations for Viral Disease Eradication

Lessons Learned and Future Strategies

2002

Biological Threats and Terrorism

Assessing the Science and Response Capabilities

2002

Emerging Infectious Diseases from the Global to Local Perspective

2002

Managed Care Systems and Emerging Infections

Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention

2000

Antimicrobial Resistance

Issues and Options

1998

Orphans and Incentives

Developing Technologies to Address Emerging Infections

1997